| 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022 | 1168 | 2022 |
| Immune checkpoint inhibitor rechallenge after immune-related adverse events in patients with cancer C Dolladille, S Ederhy, M Sassier, J Cautela, F Thuny, AA Cohen, ... JAMA oncology 6 (6), 865-871, 2020 | 351 | 2020 |
| Cardiovascular toxicity related to cancer treatment: a pragmatic approach to the American and European cardio‐oncology guidelines J Alexandre, J Cautela, S Ederhy, GL Damaj, JE Salem, F Barlesi, ... Journal of the American Heart Association 9 (18), e018403, 2020 | 213 | 2020 |
| Focus on cannabinoids and synthetic cannabinoids R Le Boisselier, J Alexandre, V Lelong‐Boulouard, D Debruyne Clinical Pharmacology & Therapeutics 101 (2), 220-229, 2017 | 183 | 2017 |
| Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study … PM Morice, A Leary, C Dolladille, B Chrétien, L Poulain, ... The Lancet Haematology 8 (2), e122-e134, 2021 | 167 | 2021 |
| Anticancer drug-induced cardiac rhythm disorders: current knowledge and basic underlying mechanisms J Alexandre, JJ Moslehi, KR Bersell, C Funck-Brentano, DM Roden, ... Pharmacology & therapeutics 189, 89-103, 2018 | 130 | 2018 |
| Cardiovascular toxicities associated with hydroxychloroquine and azithromycin: an analysis of the World Health Organization Pharmacovigilance Database LS Nguyen, C Dolladille, MD Drici, C Fenioux, J Alexandre, JP Mira, ... Circulation 142 (3), 303-305, 2020 | 110 | 2020 |
| Renin-angiotensin-aldosterone system and COVID-19 infection J Alexandre, JL Cracowski, V Richard, B Bouhanick Annales d'endocrinologie 81 (2-3), 63-67, 2020 | 101 | 2020 |
| Influence of steroid hormones on ventricular repolarization JE Salem, J Alexandre, A Bachelot, C Funck-Brentano Pharmacology & Therapeutics 167, 38-47, 2016 | 96 | 2016 |
| Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis C Dolladille, J Akroun, PM Morice, A Dompmartin, E Ezine, M Sassier, ... European Heart Journal 42 (48), 4964-4977, 2021 | 82 | 2021 |
| Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease J Alexandre, E Saloux, AE Dugue, A Lebon, A Lemaitre, V Roule, ... J Cardiovasc Magn Reson 15, 12, 2013 | 76 | 2013 |
| Clinical strategy for the diagnosis and treatment of immune checkpoint inhibitor–associated myocarditis: a narrative review LH Lehmann, J Cautela, N Palaskas, AH Baik, WC Meijers, Y Allenbach, ... JAMA cardiology 6 (11), 1329-1337, 2021 | 74 | 2021 |
| Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors C Dolladille, S Ederhy, S Allouche, Q Dupas, R Gervais, J Madelaine, ... Journal for immunotherapy of cancer 8 (1), 2020 | 70 | 2020 |
| Electrocardiographic manifestations of immune checkpoint inhibitor myocarditis JR Power, J Alexandre, A Choudhary, B Ozbay, S Hayek, A Asnani, ... Circulation 144 (18), 1521-1523, 2021 | 54 | 2021 |
| Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database J Alexandre, JE Salem, J Moslehi, M Sassier, C Ropert, J Cautela, ... European Heart Journal-Cardiovascular Pharmacotherapy 7 (4), 312-320, 2021 | 52 | 2021 |
| High incidence of atrial fibrillation in patients treated with ibrutinib F Baptiste, J Cautela, Y Ancedy, N Resseguier, T Aurran, L Farnault, ... Open Heart 6 (1), e001049, 2019 | 49 | 2019 |
| TRPM4 non‐selective cation channels influence action potentials in rabbit Purkinje fibres T Hof, L Sallé, L Coulbault, R Richer, J Alexandre, R Rouet, A Manrique, ... The Journal of physiology 594 (2), 295-306, 2016 | 49 | 2016 |
| Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized controlled … V Roule, P Ardouin, K Blanchart, A Lemaitre, J Wain-Hobson, D Legallois, ... Critical Care 20, 1-7, 2016 | 48 | 2016 |
| Acute coronary syndrome with immune checkpoint inhibitors: a proof-of-concept case and pharmacovigilance analysis of a life-threatening adverse event J Cautela, F Rouby, JE Salem, J Alexandre, U Scemama, C Dolladille, ... Canadian Journal of Cardiology 36 (4), 476-481, 2020 | 38 | 2020 |
| Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication S Ederhy, C Dolladille, F Thuny, J Alexandre, A Cohen European journal of heart failure 21 (7), 945-947, 2019 | 38 | 2019 |
Charles DolladillePharmacology DepartmentAdresse e-mail validée de chu-caen.fr
